Log on / register
Feedback | Support | My details
Antibody-mediated delivery of IL-10 inhibits the progression of established collagen-induced arthritis.
Trachsel E, Bootz F, Silacci M, Kaspar M, Kosmehl H, Neri D
Arthritis Res Ther 2007, 9:R9
[Full text] [PubMed] [Related articles] [F1000 Medicine] [Cited on BioMed Central]


printer friendly 
to  [Help]

BioMed Central articles that cite the above article:

1.


Research article
Preclinical characterization of DEKAVIL (F8-IL10), a novel clinical-stage immunocytokine which inhibits the progression of collagen-induced arthritis
Schwager K, Kaspar M, Bootz F, Marcolongo R, Paresce E, Neri D, Trachsel E
Arthritis Research & Therapy 2009, 11:R142 (25 September 2009)
[Full text] [PubMed Central] [PubMed] [Related articles] [Cited on BioMed Central]

You can also check ISI Web of Science for additional citations (subscription required)
printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.